Stay updated on RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.

Latest updates to the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.6%
- Check15 days agoChange DetectedDifference0.5%
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase II study on combining radiosurgery and Nivolumab for treating brain metastases, while adding new identifiers and collaborators.SummaryDifference34%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.6%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check52 days agoChange DetectedDifference0.5%
Stay in the know with updates to RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.